IPO registrations (S-1, F-1) · Registrants
AbbVie Inc.
- SEC CIK
- 1551152 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2012-12-10, last 2012-12-19; 1 initial registration, 1 amendment
- Outcome
- Declared effective 2012-12-31
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 1 NORTH WAUKEGAN ROAD, North Chicago, IL 60064
- EIN
- 32-0375147
- Ticker
- ABBV (NYSE)
- EDGAR entity type
- operating
- Insiders and CEO pay
- AbbVie Inc. on the corporate pages
Offering terms
- Shares offered
- 16,000,000
- Listing
- NYSE under the symbol ABBV
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: ABBVIE INC. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: AbbVie Inc. Fuzzy (name and state)
- Business registration: AbbVie Inc. Fuzzy (name and state)
- Business registration: AbbVie Inc. Fuzzy (name and state)
- Business registration: AbbVie Inc. Fuzzy (name and state)
- Business registration: ABBVIE Inc. Fuzzy (name and state)
- Business registration: ABBVIE INC. Fuzzy (name and state)
- Business registration: ABBVIE INC. Fuzzy (name and state)
- Business registration: ABBVIE INC. Fuzzy (name and state)
- Business registration: ABBVIE INC. Fuzzy (name and state)
- Form 5500 plan sponsor: ABBVIE INC. EXACT (EIN (EXACT))
- Political committee (FEC): ABBVIE POLITICAL ACTION COMMITTEE (connected to ABBVIE) Fuzzy (name and state)
- Form D issuer: AbbVie Inc. EXACT (CIK (EXACT))
- Lobbying client: ABBVIE Fuzzy (name and state)
- Lobbying client: ABBVIE Fuzzy (name and state)
- Lobbying client: ABBVIE Fuzzy (name and state)
- Lobbying client: ABBVIE INC. Fuzzy (name and state)
- Lobbying client: ABBVIE INC. Fuzzy (name and state)
- Lobbying client: ABBVIE INC. Fuzzy (name and state)
- Lobbying client: ABBVIE INC. Fuzzy (name and state)
- Lobbying client: ABBVIE INC. Fuzzy (name and state)
- Lobbying client: ABBVIE INC. Fuzzy (name and state)
- SEC filer: AbbVie Inc. EXACT (CIK (EXACT))
- Person page: Brett J Hart Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: Glenn F Tilton Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: Greg W Linder Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: Perry C Siatis Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer))
- Person page: Thomas C Freyman Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 4
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2012-12-10 | S-1 | S-1 (registration) | AbbVie Inc. | 0001047469-12-011130 ↗ |
| 2012-12-19 | S-1/A | S-1/A (amendment) | AbbVie Inc. | 0001047469-12-011329 ↗ |
| 2012-12-31 | EFFECT | EFFECT (declared effective) | AbbVie Inc. | 9999999995-13-000012 ↗ |
| 2013-07-08 | EFFECT | EFFECT (declared effective) | AbbVie Inc. | 9999999995-13-002025 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2012-12-19 | S-1/A | registration statement | 16,000,000 | - | NYSE ABBV | 0 | primary document; shares headline | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| ABBOTT LABORATORIES | TenPercentOwner | 2 | 2012 | ||
| ALBAN CARLOS | Officer | EVP, Commercial Operations; Vice Chairman | 24 | 2012–2020 | |
| CHASE WILLIAM J | Officer | EVP, Chief Financial Officer; EVP, Finance & Administration | 22 | 2012–2019 | |
| FREYMAN THOMAS C | Director | 12 | 2012–2026 | person page Fuzzy | |
| GONZALEZ RICHARD A | Director; Director,Officer; Officer | Chairman of the Board and CEO; CHAIRMAN OF THE BOARD AND CEO; EXECUTIVE CHAIRMAN OF BOARD | 71 | 2012–2025 | |
| HURWICH THOMAS A. | Officer | VP, Controller | 20 | 2012–2017 | |
| LEONARD JOHN M. | Officer | SVP, Chief Scientific Officer | 6 | 2012–2013 | |
| LINDER GREG W | Director | 1 | 2012 | person page Fuzzy | |
| RICHMOND TIMOTHY J. | Officer | EVP, Chief HR Officer; EVP, CHIEF HR OFFICER; SVP, Human Resources | 41 | 2012–2025 | |
| SALEKI-GERHARDT AZITA | Officer | EVP, CHIEF OPERATIONS OFFICER; EVP, Operations; EVP, OPERATIONS; SVP, Operations | 50 | 2012–2026 | |
| Schumacher Laura J | Officer; Other | EVP, Bus.Dev., Ext.Aff. & GC; EVP, Bus.Dev.,Ext.Aff.&GC; Executive Vice President; Vice Chairman | 48 | 2012–2022 | |
| WADDELL FREDERICK H | Director | 16 | 2012–2026 | ||
| Alpern Robert J | Director | 68 | 2012–2026 | ||
| AUSTIN ROXANNE S | Director | 21 | 2012–2026 | ||
| BURNSIDE WILLIAM H.L. | Director | 15 | 2012–2026 | ||
| LIDDY EDWARD M | Director | 42 | 2012–2022 | ||
| RAPP EDWARD J | Director | 74 | 2012–2026 | ||
| ROBERTS ROY S | Director | 4 | 2012–2015 | ||
| TILTON GLENN F | Director | 36 | 2012–2025 | person page Fuzzy | |
| SEVERINO MICHAEL | Officer | EVP, R&D and CSO; Vice Chairman | 27 | 2014–2022 | |
| Gosebruch Henry O | Officer | Chief Strategy Officer; EVP, Chief Strategy Officer | 31 | 2015–2022 | |
| Hart Brett J | Director | 12 | 2016–2026 | person page Fuzzy | |
| Michael Robert A. | Director,Officer; Officer | CHAIRMAN OF THE BOARD AND CEO; CHIEF EXECUTIVE OFFICER; EVP, Chief Financial Officer; PRES & CHIEF OPERATING OFFICER; SVP, Chief Financial Officer; Vice Chairman; VICE CHAIRMAN; VP, Controller | 22 | 2017–2026 | |
| MEYER MELODY B | Director | 11 | 2017–2026 | ||
| Roberts Rebecca B | Director | 10 | 2018–2026 | ||
| Durkin Brian L | Officer | VP, Controller; VP, CONTROLLER | 19 | 2018–2023 | |
| Stewart Jeffrey Ryan | Officer | EVP, Chief Commercial Officer; EVP, CHIEF COMMERCIAL OFFICER; EVP, Commercial Operations; EVP, COMMERCIAL OPERATIONS; SVP, US Commercial Operations | 30 | 2018–2026 | |
| Donoghoe Nicholas | Officer | EVP, Chief Bus/Strat Officer; EVP, CHIEF BUS/STRAT OFFICER; SVP, Enterprise Innovation | 18 | 2019–2026 | |
| Hudson Thomas J | Officer | SVP, CSO, GLOBAL RESEARCH; SVP, R&D and CSO; SVP, R&D AND CSO | 11 | 2019–2024 | |
| Strom Carrie C | Officer | SVP & Pres Global Allerg Aesth; SVP & PRES GLOBAL ALLERG AESTH | 22 | 2020–2023 | |
| Sorg Elaine K. | Officer | Sr. V.P., U.S. Commercial Ops.; SVP, US Commercial Operations; SVP, US COMMERCIAL OPERATIONS | 13 | 2020–2023 | |
| Reents Scott T | Officer | EVP, CHIEF FINANCIAL OFFICER; SVP, Chief Financial Officer | 10 | 2022–2026 | |
| Siatis Perry C | Officer | EVP, GC and Secretary; EVP, GC AND SECRETARY | 15 | 2022–2026 | person page Fuzzy |
| Buckbee Kevin K | Officer | SVP, Controller; SVP, CONTROLLER | 7 | 2023–2025 | |
| Davis Jennifer L. | Director | 4 | 2023–2026 | ||
| Quaggin Susan E | Director | 15 | 2023–2026 | ||
| Thakkar Roopal | Officer | EVP, R&D and CSO; SVP, CMO, GLOBAL THERAPEUTICS; SVP, Global Therapeutics & CMO | 8 | 2023–2026 | |
| Purdue David Ryan | Officer | SVP, Controller | 5 | 2025–2026 | |
| FALK THOMAS J | Director | 3 | 2025–2026 | ||
| AbbVie Inc. | Officer | EVP, Chief HR Officer | 1 | 2025 | |
| Crum Demetris D | Officer | EVP, Chief HR Officer; EVP, CHIEF HR OFFICER | 3 | 2025–2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2016-05-09 | AbbVie Inc. | Pharmaceuticals | $3,800,000,000 | $3,800,000,000 | 39 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | ABBVIE INC. | IL | State business registries | EIN (EXACT, as the state registration reports it) |
| Form D issuer | AbbVie Inc. | IL | Form D private offerings | CIK (EXACT) |
| SEC filer | AbbVie Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Business registration | AbbVie Inc. | State business registries | name and state | |
| Business registration | AbbVie Inc. | State business registries | name and state | |
| Business registration | AbbVie Inc. | State business registries | name and state | |
| Business registration | AbbVie Inc. | State business registries | name and state | |
| Business registration | ABBVIE Inc. | State business registries | name and state | |
| Business registration | ABBVIE INC. | State business registries | name and state | |
| Business registration | ABBVIE INC. | State business registries | name and state | |
| Business registration | ABBVIE INC. | State business registries | name and state | |
| Business registration | ABBVIE INC. | State business registries | name and state | |
| Form 5500 plan sponsor | ABBVIE INC. | EIN (EXACT) | ||
| Political committee | ABBVIE POLITICAL ACTION COMMITTEE (connected to ABBVIE) | Campaign finance (FEC) | name and state | |
| Lobbying client | ABBVIE | Federal lobbying (LDA) | name and state | |
| Lobbying client | ABBVIE | Federal lobbying (LDA) | name and state | |
| Lobbying client | ABBVIE | Federal lobbying (LDA) | name and state | |
| Lobbying client | ABBVIE INC. | Federal lobbying (LDA) | name and state | |
| Lobbying client | ABBVIE INC. | Federal lobbying (LDA) | name and state | |
| Lobbying client | ABBVIE INC. | Federal lobbying (LDA) | name and state | |
| Lobbying client | ABBVIE INC. | Federal lobbying (LDA) | name and state | |
| Lobbying client | ABBVIE INC. | Federal lobbying (LDA) | name and state | |
| Lobbying client | ABBVIE INC. | Federal lobbying (LDA) | name and state | |
| Person page | Brett J Hart | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | Glenn F Tilton | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | Greg W Linder | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | Perry C Siatis | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer) | |
| Person page | Thomas C Freyman | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, IL first:
- APP Pharmaceuticals, Inc. IL
- XERIS PHARMACEUTICALS INC IL
- Sagent Pharmaceuticals, Inc. IL
- Wellness Center USA, Inc. IL
- Durata Therapeutics, Inc. IL
- PharMEDium Healthcare Holdings, Inc. IL
- Baxalta Inc IL
- Accelerated Pharma, Inc. IL
- Monopar Therapeutics IL
- Aptinyx Inc. IL
In other datasets, the same topic (Health) in IL:
- Nonprofit: 5 LOAVES 2 FISHES FOUNDATION INC (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health